Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Conditions
Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The University of Alabama at Birmingham, Birmingham, Alabama, United States
UC San Diego Health, La Jolla, California, United States
Cedars Sinai Medical Center, Los Angeles, California, United States
Mayo Clinic Jacksonville, Jacksonville, Florida, United States
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Advent Health Cancer Institute, Orlando, Florida, United States
Tampa General Hospital Cancer Institute, Tampa, Florida, United States
University of Chicago, Chicago, Illinois, United States
The University of Kansas Cancer Center, Westwood, Kansas, United States
Norton Cancer Institute, St. Matthews Clinic, Louisville, Kentucky, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
The Ohio State University Comprehensive Cancer Center, Hilliard, Ohio, United States
Providence Cancer Institute, Portland, Oregon, United States
University of Pittsburgh Medical Center, Magee-Womens Hospital, Pittsburgh, Pennsylvania, United States
West Penn Hospital of Allegheny Health Network, Pittsburgh, Pennsylvania, United States
Avera Cancer Institute Sioux Falls, Sioux Falls, South Dakota, United States
UT Southwestern Medical Center, Dallas, Texas, United States
Swedish Cancer Institute, Seattle, Washington, United States
University of Wisconsin, Madison, Wisconsin, United States
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
CancerCare Manitoba, Winnipeg, Manitoba, Canada
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Centre de Santé et de Services Sociaux de la Montérégie-Centre, Greenfield Park, Quebec, Canada
Research Institute - McGill University Health Centre, Montreal, Quebec, Canada
Centre Hospitalier Universitaire (CHU) de Quebec - Universite Laval, Québec, Canada
National Cancer Center, Gyeonggi-do, Gyeonggi-do, South Korea
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea
Gachon University Gil Medical Center, Incheon, Seoul, South Korea
Keimyung University Dongsan Hospital, Daegu, South Korea
Severance Hospital Yonsei University Health System, Seoul, South Korea
Asan Medical Center, Univ. of Ulsan, Seoul, South Korea
Samsung Medical Center, Seoul, South Korea
Gangnam Severance Hospital, Seoul, South Korea
Seoul National University Hospital, Seoul, South Korea
Korea University Guro Hospital, Seoul, South Korea
Changhua Christian Hospital, Changhua, Changhua City, Taiwan
Chi Mei Medical Center, Tainan, Taiwan
Mackay Memorial Hospital, Taipei, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
Taipei Veterans General Hospital, Taipei, Taiwan
Tri-Service General Hospital, Taipei, Taiwan
Taipei Municipal Wan Fang Hospital, Taipei, Taiwan
Medicalpark Seyhan Hospital, Seyhan, Adana, Turkey (Türkiye)
Hacettepe University, Altındağ, Ankara, Turkey (Türkiye)
Medipol University Hospital, Istanbul, Bagcilar, Turkey (Türkiye)
Gaziantep Medicalpoint Hospital, Gaziantep, Sehitkamil, Turkey (Türkiye)
Baskent University, Adana, Turkey (Türkiye)
Sbu Doctor Abdurrahman Yurtaslan Ankara Onkoloji Suam, Ankara, Turkey (Türkiye)
Ankara Bilkent City Hospital, Ankara, Turkey (Türkiye)
Memorial Ankara Hospital, Ankara, Turkey (Türkiye)
Cerrahpasa Medical Faculty At Istanbul University Cerrahpasa, Istanbul, Turkey (Türkiye)
Izmir Ekonomi Universitesi (IEU) Medical Point Izmir Hastanesi (Izmir Economy University Medical Point Izmir Hospital), Izmir, Turkey (Türkiye)
Sakarya University - Education and Research Hospital, Sakarya, Turkey (Türkiye)
Study leads
Clinical Trial Management
Study Director
Regeneron Pharmaceuticals